Clinical trialNCT06840496RecruitingPhase 3Interventional

To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome

SponsorBiomed Industries, Inc.Enrollment210Rett Syndrome

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Primary Objective • To investigate the efficacy of treatment with oral Bionetide versus placebo in girls and women with Rett syndrome Key Secondary Objective • To investigate the efficacy of treatment with oral Bionetide versus placebo on ability to communicate in girls and women with Rett syndrome

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

David Nguyen, PhD
Biomed Industries, Inc.
Study Director
clinicaltrials.gov ↗
Lloyd L Tran, PhD
Biomed Industries, Inc.
Study Director
clinicaltrials.gov ↗
Zung V Tran, PhD
Biomed Industries, Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Biomed Research Unit-Bio-23-Nsw 2050
Camperdown, New South Wales, Australia
Recruiting
Biomed Research Unit-Bio-24-Nsw-4101
South Brisbane, Queensland, Australia
Recruiting
Biomed Research Unit-Bio-21-Vic-3084
Heidelberg West, Victoria, Australia
Recruiting
Biomed Research Unit- Bio-22-Vic 3010
Parkville, Victoria, Australia
Recruiting

United States

Biomed Testing Facility # Bio-01-85012
Phoenix, Arizona, United States
Recruiting
Biomed Testing Facility # Bio-05-92093
La Jolla, California, United States
Recruiting
Biomed Testing Facility # Bio-04-90095
Los Angeles, California, United States
Recruiting
Biomed Testing Facility # Bio-03-95817
Sacramento, California, United States
Recruiting
Biomed Testing Facility # Bio-02-94104
San Francisco, California, United States
Recruiting
Biomed Testing Facility #bio-06-80042
Aurora, Colorado, United States
Recruiting
Biomed Testing Facility #bio-07-33606
Tampa, Florida, United States
Recruiting
Biomed Testing Facility #bio-08-60612
Chicago, Illinois, United States
Recruiting
Maryland Locations Biomed Testing Facility #bio-9-21205
Baltimore, Maryland, United States
Recruiting
Biomed Testing Facility #bio-10-02115
Boston, Massachusetts, United States
Recruiting
Biomed Testing Facility #bio-13-10467
The Bronx, New York, United States
Recruiting
Biomed Testing Facility #bio-17-19104
Philadelphia, Pennsylvania, United States
Recruiting
Biomed Testing Facility #bio-19-77030
Houston, Texas, United States
Recruiting
Biomed Testing Facility #bio-20-98105
Seattle, Washington, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

BionetidePlacebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2026
Primary completion: 30 Sept 2027
Completion: 30 Dec 2027
Last update posted: 27 Mar 2026
Registered enrollment: 210
Registry id: NCT06840496

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.